NCT05568667

Brief Summary

It has been estimated that 19,000 Colorectal Cancers (CRC) could be prevented each year in France by changing individual risk behaviours (sedentary lifestyle, overweight, diet, alcohol). The cancer screening appears to be an opportune moment for health promotion and to inform about CRC risk factors. The PRECÔTION study proposes an innovative scheme based on informative, motivational and community-based approaches. The objectives are to take advantage of patients' visits for colonoscopy to raise awareness and initiate individual prevention actions according to their own risk in order to modify individual risk behaviour. Patients who come for a colonoscopy at the Centre Léon Bérard and who are negative (80% of cases) will benefit from an evaluation to identify their individual risk factors, determine their level of risk level for CRC and their motivation to change their behaviour. Participants with a low level of risk will receive remote support in physical activity and nutrition via digital media based on a motivational approach. Participants will be proposed a monthly collective physical activity session, which will allow them to interact with each other and develop a community approach. Participants with an intermediate level of risk will be offered a collective health education session, in addition to the the support offered to participants with a low level of risk. Participants with a high level of risk will receive, in addition to the the support offered to participants with an intermediate level of risk, an individual motivational coaching and a connected watch. A logbook will also be given to all participants to accompany them on the different tools, especially for monitoring their goals. The PRECÔTION study aims to evaluate these tools as innovative means of prevention before evaluate their effectiveness on a larger scale.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 3, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 6, 2022

Completed
11 days until next milestone

Study Start

First participant enrolled

October 17, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2023

Completed
Last Updated

February 12, 2024

Status Verified

March 1, 2023

Enrollment Period

1.1 years

First QC Date

October 3, 2022

Last Update Submit

February 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of the programme feasability

    Participation rate at each modality of the programme

    Month 6

Secondary Outcomes (6)

  • Assessment of the programme acceptability

    Month 6

  • Assessment of the programme acceptability

    Month 6

  • Assessment of the programme observance

    Month 6

  • Assessment of the evolution of lifestyle

    Month 6

  • Assessment of the physical activity level change

    Month 6

  • +1 more secondary outcomes

Study Arms (1)

Risk sub-group

EXPERIMENTAL

1. st sub-grouup : Low risk to develop a CRC 2. nd sub-group : Moderate risk to develop a CRC 3. rd sub-group : High risk to develop a CRC

Behavioral: Low riskBehavioral: Moderate riskBehavioral: High risk

Interventions

Low riskBEHAVIORAL

* remote support in physical activity and nutrition via digital media * monthly collective physical activity sessions * logbook

Risk sub-group
Moderate riskBEHAVIORAL

* remote support in physical activity and nutrition via digital media * monthly collective physical activity sessions * one collective health education session * logbook

Risk sub-group
High riskBEHAVIORAL

* remote support in physical activity and nutrition via digital media * monthly collective physical activity sessions * one collective health education session * 3 individual sessions of motivational coaching * connected watch * logbook

Risk sub-group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • I1. Adult aged ≤ 80 years,
  • I3. Willing to be involved throughout the study,
  • I4. Able to practice a adapted physical activity (APA) certified by a medical certificate issued by the referring oncologist or the clinical investigator,
  • I5. Using a own smartphone, a tablet or a PC with Internet connexion,
  • I6. Having a valid health insurance affiliation,
  • I7. Having dated and signed an informed consent form,
  • I8. Able to read, write and understand French.

You may not qualify if:

  • NI1. Presence of a primary cancer (other than in situ cancer of any location and/or basal cell skin cancer) - NB : people in complete remission from a previous cancer may be included,
  • NI2. With a contraindication to pratice physical activity (e.g. uncontrolled hypertension, uncontrolled heart disease),
  • NI3. Severe undernutrition (HAS) (i.e. weight loss ≥ 10% in 1 month or ≥ 15% in 6 months or ≥ 15% compared to usual weight or body mass index ≤ 17 kg/m² for a person \< 70 ans or body mass index \< 20 kg/m² for a person ≥ 70 ans)
  • NI4. Unable to be followed for medical, social, family, geographical or psychological reasons throughout the study,
  • NI5. Deprived of liberty by judicial or administrative decision,
  • NI6. Concurrent participation in another PA or nutrition study,
  • NI7. (For women) Pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Léon Bérard (CLB)

Lyon, 69008, France

Location

MeSH Terms

Interventions

AIEOP acute lymphoblastic leukemia protocol

Study Officials

  • Anne CATTEY-JAVOUHEY, MD, PhD

    Centre Leon Berard

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2022

First Posted

October 6, 2022

Study Start

October 17, 2022

Primary Completion

December 6, 2023

Study Completion

December 6, 2023

Last Updated

February 12, 2024

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations